The new entries in the therapeutic armamentarium: The small molecule JAK inhibitors - ScienceDirect
/jak-inhibitors-4706526-FINAL-3461d4fc6ce44f54801ef59489afa62c.png "JAK Inhibitors: Uses, Drug Options, and Side Effects")
JAK Inhibitors: Uses, Drug Options, and Side Effects
Frontiers | Emerging Topical and Systemic JAK Inhibitors in Dermatology | Immunology
References in Emerging therapies for atopic dermatitis: JAK inhibitors - Journal of the American Academy of Dermatology
JAK inhibitors for the treatment of autoimmune and inflammatory diseases - ScienceDirect
Work to do in convincing physicians of JAK inhibitors in PsA, says survey
JAK selectivity and the implications for clinical inhibition of pharmacodynamic cytokine signalling by filgotinib, upadacitinib, tofacitinib and baricitinib | Annals of the Rheumatic Diseases
A comparison of Janus kinase inhibitor safety in rheumatoid arthritis - Nash - 2021 - International Journal of Rheumatic Diseases - Wiley Online Library
Janus Kinase Inhibitors in Dermatology: Part 1 — General Considerations and Applications in Vitiligo and Alopecia Areata | Actas Dermo-Sifiliográficas
Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19: Trends in Pharmacological Sciences
Janus Kinase Inhibitors Offer New Treatment for Rheumatoid Arthritis, Psoriatic Arthritis, Colitis
References in JAK inhibitors in 2019, synthetic review in 10 points - European Journal of Internal Medicine
JAK inhibitors prevent JAK activation. The signaling cascade that... | Download Scientific Diagram
![PDF] Clinical significance of Janus Kinase inhibitor selectivity | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/fde76c10640b352648c21c3146bef98d22fa5186/2-Figure1-1.png "PDF] Clinical significance of Janus Kinase inhibitor selectivity | Semantic Scholar")
PDF] Clinical significance of Janus Kinase inhibitor selectivity | Semantic Scholar
Selective JAKinibs: Prospects in Inflammatory and Autoimmune Diseases | SpringerLink
HiJAKing SARS-CoV-2? The potential role of JAK inhibitors in the management of COVID-19
JAK inhibitors in the treatment of atopic dermatitis - Journal of Allergy and Clinical Immunology
IJMS | Free Full-Text | Clinical Aspects of Janus Kinase (JAK) Inhibitors in the Cardiovascular System in Patients with Rheumatoid Arthritis
The emerging safety profile of JAK inhibitors in rheumatic disease | Nature Reviews Rheumatology
JAK Inhibitors Are Coming and They Are the Biggest Eczema Development in Years | National Eczema Association
Selective JAK inhibitors | Future Medicinal Chemistry
JAK inhibitor safety: Distilling the evidence | rheumatology.medicinematters.com
The Potential of JAK/STAT Pathway Inhibition as a New Treatment Strategy to Control Cytokine Release Syndrome in COVID-19 | Biological and Medicinal Chemistry | ChemRxiv | Cambridge Open Engage
Frontiers | Impact of Janus Kinase Inhibition on the Treatment of Axial Spondyloarthropathies | Immunology
Rheumatoid arthritis | JAK inhibitors: The next generation of drugs for treating rheumatoid arthritis? | rheumatology.medicinematters.com
